MIRABEGRON

MIRABEGRON: MIRABEGRON is a medication that is primarily used for the treatment of Overactive Bladder (OAB). OAB is a condition characterized by a frequent need to urinate, urgency, and incontinence.

The mechanism of action of MIRABEGRON involves stimulating the beta-3 adrenergic receptors in the bladder, which leads to relaxation of the bladder muscle. This relaxation allows the bladder to store urine more effectively, reducing urgency and improving bladder control.

The usual recommended dose of MIRABEGRON is 25 mg once daily. Some patients may require a higher dose of 50 mg per day if the lower dose is not sufficient. It is important to follow the dosage instructions provided by the healthcare professional.

Common side effects associated with MIRABEGRON may include hypertension (high blood pressure), increased heart rate, urinary tract infection, headache, dizziness, and constipation. These side effects are generally mild and temporary. However, it is essential to consult a healthcare provider if any severe or persistent side effects occur.

MIRABEGRON may not be suitable for everyone, and it is important to disclose any pre-existing medical conditions or medications being taken to the healthcare professional before starting treatment. They can help determine if this medication is the right option for the individual and adjust the dose accordingly to optimize its effectiveness while minimizing side effects.